Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties

Hepatology

Volumn 44, Issue 1, 2006, Pages 240-251

  Chiba, Tetsuhiro ^a,b   Kita, Kaoru ^a   Zheng, Yun Wen ^a   Yokosuka, Osamu ^b   Saisho, Hiromitsu ^b   Iwama, Atsushi ^b   Nakauchi, Hiromitsu ^c   Taniguchi, Hideki ^a,d,e  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d RIKEN   (Japan)

^e NATIONAL INSTITUTE FOR MATERIALS SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; CELL FRACTIONATION; CELL FUNCTION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELL SELECTION; CELL SUBPOPULATION; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DISEASE SEVERITY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIVER CELL; LIVER CELL CARCINOMA; MICROARRAY ANALYSIS; OBESITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VALIDATION STUDY; XENOGRAFT; XENOTRANSPLANTATION;

ALPHA-FETOPROTEINS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LIVER NEOPLASMS; NEOPLASM TRANSPLANTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TRANSPLANTATION, HETEROLOGOUS; TUMOR STEM CELLS;

EID: 33745924696     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21227     Document Type: Article

References (47)

1. Fialkow PJ, Gartler SM, Yoshida A. Clonal origin of chronic myelocytic leukemia in man. Proc Natl Acad Sci U S A 1967;58:1468-1471.
2. Grunstein M. Acute myeloblastic leukemia considered as a clonal hemopathy. Blood cells 1979;15:261-282.
3. Heppner GH. Tumor heterogeneity. Cancer Res 1984;44:2259-2265.
4. Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells. Cell Science 1977;197:461-463.
5. Bruce WR, Van Der Gaag H. A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 1963;199:79-80.
6. Southam CM, Brunschwig A. Quantitative studies of autotransplantation of human cancer. Cancer 1961;14:971-978.
7. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994;367:645-648.
8. Warner JK, Wang JC, Hope KJ, Jin L, Dick JE. Concepts of human leukemic development. Oncogene 2004;23:7164-7177.
9. Wang JC, Dick JE. Cancer stem cells: lessons from leukemia. Trends Cell Biol 2005;15:494-501.
10. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-737.
11. Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003;423:255-260.
12. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003;100:3983-3988.
13. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature 2004;432:396-401.
14. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.
15. Okuda K. Hepatocellular carcinoma: recent progress. HEPATOLOGY 1992;15:948-963.
16. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789-799.
17. Lund AH, van Lohuizen M. Epigenetics and cancer. Genes Dev 2004;18:2315-2335.
18. Satyanarayana A, Manns MP, Rudolph KL. Telomeres and telomerase: a dual role in hepatocarcinogenesis. HEPATOLOGY 2004;40:276-283.
19. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996;183:1797-1806.
20. Shimano K, Satake M, Okaya A, Kitanaka J, Kitanaka N, Takemura M, et al. Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP1. Am J Pathol 2003;163:3-9.
21. Falciatori I, Borsellino G, Haliassos N, Boitani C, Corallini S, Battistini L, et al. Identification and enrichment of spermatogonial stem cells displaying side-population phenotype in immature mouse testis. FASEB J 2004;18:376-378.
22. Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A 2004;101:781-786.
23. Itsubo M, Ishikawa T, Toda G, Tanaka M. Immunohistochemical study of expression and cellular localization of the multidrug resistance gene product P-glycoprotein in primary liver carcinoma. Cancer (Phila) 1994;73:298-303.
24. Kangas L, Gronroos M, Nieminen AL. Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro. Med Biol 1984;62:338-343.
25. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA. "Sternness": transcriptional profiling of embryonic and adult stem cells. Science 2002;298:597-600.
26. Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, Lemischka IR. A stem cell molecular signature. Science 2002;298:601-604.
27. Chiba T, Yokosuka O, Fukai K, Kojima H, Tada T, Arai M, et al. Cell growth inhibition and gene expression induced by histone deacetylase inhibitor, Trichostatin A, on human hepatoma cells. Oncology 2004;66:481-491.
28. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 2005;65:6207-6219.
29. Domen J, Gandy KL, Weissman IL. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood 1998;91:2272-2282.
30. Feuerhake F, Sigg W, Hofter EA, Dimpfl T, Welsch U. Immunohistochemical analysis of Bcl-2 and Bax expression in relation to cell turnover and epithelial differentiation markers in the non-lactating human mammary gland epithelium. Cell Tissue Res 2000;299:47-58.
31. Kawai HF, Kaneko S, Honda M, Shirota Y, Kobayashi K. Alpha-fetoprotein- producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis. HEPATOLOGY 2001;33:676-691.
32. Wu F, Nishioka M, Fujita J, Murota M, Ohtsuki Y, Ishida T, et al. Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines. Int J Oncol 2002;20:31-37.
33. Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, Mandl S, et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 2004;431:1112-1117.
34. Uenishi T, Kubo S, Yamamoto T, Shuto T, Ogawa M, Tanaka H, et al. Cytokeratin 19 expression in hepatocellular carcinoma predicts early post-operative recurrence. Cancer Sci 2003;94:851-857.
35. Zheng YW, Taniguchi H. Diversity of hepatic stem cells in the fetal and adult liver. Semin Liver Dis 2003;23:337-348.
36. Huang T, Chesnokov V, Yokoyama KK, Carr BI, Itakura K. Expression of the Hoxa-13 gene correlates to hepatitis B and C virus associated HCC. Biochem Biophys Res Commun 2001;281:1041-1044.
37. Lee JS, Thorgeirsson SS. Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer. HEPATOLOGY 2002;35:1134-1143.
38. Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. HEPATOLOGY 2004;40:667-676.
39. Shirota Y, Kaneko S, Honda M, Kawai HF, Kobayashi K. Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays. HEPATOLOGY 2001:33:832-840.
40. Suzuki A, Zheng YW, Fukao K, Nakauchi H, Taniguchi H. Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver. J Cell Biol 2002;156:173-184.
41. Reya T, devers H. Wnt signalling in stem cells and cancer. Nature 2005;434:843-850.
42. Merle P, de la Monte S, Kim M, Herrmann M, Tanaka S, Von Dem Bussche A, et al. Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. Gastroenterology 2004;127:1110-1122.
43. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001;7:1028-1034.
44. Zhou S, Morris JJ, Barnes Y, Lan L, Schuetz JD, Sorrentino BP. Bcrpl gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc Natl Acad Sci U S A 2002;99:12339-12344.
45. Bunting KD, Zhou S, Lu T, Sorrentino BP. Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo. Blood 2000;96:902-909.
46. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A 2004;101:14228-14233.
47. Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF, et al. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 2006;24:506-511.